# Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets

> **NCT00483002** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 3719 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** varenicline

## Key facts

- **NCT ID:** NCT00483002
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 3719 (ACTUAL)
- **Last updated:** 2012-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483002, "Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00483002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*